Latest Videos |view all videos
C. Burcin Taner, M.D., chair of Transplant Surgery at Mayo Clinic's campus in Florida and the study's senior investigator, discusses study finding. The liver transplant team at Mayo Clinic's campus in Florida has found, based on 12 years ...
Donald Jenkins, M.D., Mayo Clinic trauma director, describes how collaboration between military and civilian trauma surgeons improves care for all patients.
Interrupting the blood flow for more than 20 to 25 minutes during kidney cancer surgery leads to a greater risk for patients developing chronic kidney disease
Robert D. McBane II, M.D., Randall R. DeMartino M.D., Thomas C. Bower, M.D., and Alberto Pochettino, M.D., discuss when to intervene in Type B thoracic aortic dissection cases.
Steve R. Ommen, M.D., and Raul E. Espinosa, M.D., weigh in on the interaction of the tricuspid valve prosthesis with pacemakers and defibrillators.
The following is a presentation by Sophie J. Bakri, M.D., titled "Vitreoretinal Management of Anterior Segment Surgical Complications" presented at the Mayo Clinic Retina Update and Case Conference.
Steve R. Ommen, M.D., and Hartzell V. Schaff, M.D., retrace the evolution of hypertrophic cardiomyopathy from the first procedure done at Mayo Clinic to current management.
Robert Widmer, MD, PhD, and Rakesh M. Suri, MD, DPhil discuss the practical takeaways from a recent study comparing valve repair with valve replacement in patients with severe ischemic MR.
Charanjit (Chet) Rihal, MD, Maurice Sarano, MD, and Rakesh Suri, MD, DPhil, discuss the results of a recently published study demonstrating that early repair for severe asymptomatic mitral regurgitation was associated with better survival.
In a video originally posted on TheHeart.org | Medscape Cardiology, Vuyisile T. Nkomo, M.D., M.P.H., interviews David R. Holmes Jr., M.D., on the transcatheter valve therapy (TVT) registry and CHOICE trial data from the American College ...
Judy C. Boughey, M.D., presents Less Invasive Axillary Surgery after Neoadjuvant Chemotherapy in Women who Present With Node-Positive Breast Cancer — Results From a Prospective Clinical Trial: ACOSOG Z1071.
Among the more than 120,000 Americans waiting for an organ transplant, thousands are told their likelihood of rejection may be too high to take the risk. However, at Mayo Clinic, some of these highly sensitized patients are still being ...